McCormick & Company, Incorporated Non-VTG CS (MKC) Financials

MKC NYSE

Trailing 12 months to August 31, 2026

Revenue $7.7B +13.2% YoY

Net Income $1.5B +91.6% YoY

EPS (Diluted) $5.53 +92.0% YoY

Free Cash Flow $925.9M +41.3% YoY

Market Cap $12.4B as of Oct 28, 2026

Price / Sales 1.6x on $7.7B revenue, trailing 12 months to August 31, 2026

Price / Earnings 8.3x on $1.5B net income, trailing 12 months to August 31, 2026

Price / Book 1.8x on $7.0B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 28, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Aug 31, 2026 Reported Oct 1, 2026 Currency USD FYE November

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MKC SEC filings page.

McCormick & Company, Incorporated Non-VTG CS (MKC) reported $7.7B in revenue over the twelve months to Aug 31, 2026, up 13.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MKC FY2025 2026-10-24

McCormick converts modest sales growth into dependable cash while steadily reducing leverage, though its working-capital structure remains tight.

Through FY2025, operating income grew 11.2% while revenue grew 2.7%, indicating that earlier profit gains came from better conversion of sales, not rapid volume expansion. That engine paused in FY2025: gross margin fell 0.6 percentage points even as free-cash-flow margin improved 1.2 points, because lower capital spending offset only modest operating-cash improvement.

Cash generation broadly validates reported earnings: FY2025 operating cash flow was $962M, or 121.9% of net income. Free cash flow reached $740M, indicating that working-capital and non-cash items supported cash conversion rather than profits relying solely on accounting recognition.

Debt-to-equity fell from 0.7x in FY2024 to 0.5x in FY2025 while equity expanded, indicating deleveraging rather than balance-sheet-funded growth. Yet the current ratio was 0.7x, so short-term obligations exceeded current assets; the business is less leveraged overall but not conservatively funded on near-term liquidity.

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of McCormick & Company, Incorporated Non-VTG CS's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

McCormick & Company, Incorporated Non-VTG CS has an operating margin of 15.7%, meaning the company retains $16 of operating profit per $100 of revenue. This strong profitability earns a score of 82/100, reflecting efficient cost management and pricing power. This is down from 15.8% the prior year.

Growth

McCormick & Company, Incorporated Non-VTG CS's revenue grew a modest 1.7% year-over-year to $6.8B. This slow but positive growth earns a score of 35/100.

Leverage

McCormick & Company, Incorporated Non-VTG CS has elevated debt relative to equity (D/E of 0.54), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 27/100, reflecting increased financial risk.

Liquidity

McCormick & Company, Incorporated Non-VTG CS's current ratio of 0.70 is below the typical benchmark, resulting in a score of 8/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

McCormick & Company, Incorporated Non-VTG CS converts 10.8% of revenue into free cash flow ($740.4M). This strong cash generation earns a score of 69/100.

Returns

McCormick & Company, Incorporated Non-VTG CS earns a strong 13.8% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 76/100. This is down from 14.9% the prior year.

Altman Z-Score Grey Zone

2.11

McCormick & Company, Incorporated Non-VTG CS scores 2.11, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $12.4B against total liabilities of $7.4B. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

McCormick & Company, Incorporated Non-VTG CS passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed

1.22x

For every $1 of reported earnings, McCormick & Company, Incorporated Non-VTG CS generates $1.22 in operating cash flow ($962.2M OCF vs $789.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

5.46x

McCormick & Company, Incorporated Non-VTG CS earns $5.46 in operating income for every $1 of interest expense ($1.1B vs $196.2M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.0B

YoY+17.4%

QoQ+4.6%

5Y CAGR+5.5%

10Y CAGR+6.4%

McCormick & Company, Incorporated Non-VTG CS generated $2.0B in revenue in Q3 2026. This represents an increase of 17.4% from the same quarter a year earlier. Against the prior quarter it is up 4.6%.

EBITDA

$293.6M

YoY-16.1%

QoQ-16.1%

5Y CAGR-1.2%

10Y CAGR+4.1%

McCormick & Company, Incorporated Non-VTG CS's EBITDA was $293.6M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 16.1% from the same quarter a year earlier. Against the prior quarter it is down 16.1%.

Net Income

$97.6M

YoY-56.7%

QoQ-35.0%

5Y CAGR-14.4%

10Y CAGR-2.7%

McCormick & Company, Incorporated Non-VTG CS reported $97.6M in net income in Q3 2026. This represents a decrease of 56.7% from the same quarter a year earlier. Against the prior quarter it is down 35.0%.

EPS (Diluted)

$0.36

YoY-57.1%

QoQ-35.7%

5Y CAGR-14.5%

McCormick & Company, Incorporated Non-VTG CS earned $0.36 per diluted share (EPS) in Q3 2026. This represents a decrease of 57.1% from the same quarter a year earlier. Against the prior quarter it is down 35.7%.

Cash & Balance Sheet

Free Cash Flow

$112.1M

YoY-45.6%

QoQ-66.7%

5Y CAGR+10.8%

10Y CAGR+3.9%

McCormick & Company, Incorporated Non-VTG CS generated $112.1M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 45.6% from the same quarter a year earlier. Against the prior quarter it is down 66.7%.

Cash & Debt

$331.1M

YoY+248.9%

QoQ0.0%

5Y CAGR+1.2%

10Y CAGR+9.5%

McCormick & Company, Incorporated Non-VTG CS held $331.1M in cash against $2.9B in long-term debt as of Q3 2026.

Dividends Per Share

$0.48

YoY+6.7%

QoQ0.0%

McCormick & Company, Incorporated Non-VTG CS paid $0.48 per share in dividends in Q3 2026. This represents an increase of 6.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

Diluted avg 269M

McCormick & Company, Incorporated Non-VTG CS had a weighted average of 269M diluted shares in Q3 2026; the shares outstanding count is not reported for that period.

Margins & Returns

Gross Margin

39.3%

YoY+1.9pp

QoQ-0.9pp

5Y change+0.6pp

10Y change-2.3pp

McCormick & Company, Incorporated Non-VTG CS's gross margin was 39.3% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.

Operating Margin

10.7%

YoY-6.0pp

QoQ-3.5pp

5Y change-6.4pp

10Y change-4.7pp

McCormick & Company, Incorporated Non-VTG CS's operating margin was 10.7% in Q3 2026, reflecting core business profitability. This is down 6.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.5 percentage points.

Net Margin

4.8%

YoY-8.3pp

QoQ-2.9pp

5Y change-8.9pp

10Y change-6.9pp

McCormick & Company, Incorporated Non-VTG CS's net profit margin was 4.8% in Q3 2026, showing the share of revenue converted to profit. This is down 8.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.9 percentage points.

Return on Equity

1.4%

YoY-2.5pp

QoQ-0.8pp

5Y change-3.5pp

10Y change-5.9pp

McCormick & Company, Incorporated Non-VTG CS's quarterly ROE was 1.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Capital Allocation

Share Buybacks

YoY-100.0%

QoQn/m

McCormick & Company, Incorporated Non-VTG CS repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Capital Expenditures

$56.0M

YoY+6.3%

QoQ+31.1%

5Y CAGR-6.2%

10Y CAGR+5.4%

McCormick & Company, Incorporated Non-VTG CS invested $56.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 6.3% from the same quarter a year earlier. Against the prior quarter it is up 31.1%.

R&D Spending

Not reported for Q3 2026.

MKC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MKC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$7.7B	$6.8B+1.7%	$6.7B+0.9%	$6.7B+4.9%	$6.4B+0.5%	$6.3B+12.8%	$5.6B+4.7%	$5.3B+0.8%	$5.3B+12.1%	$4.7B+7.2%	$4.4B+2.7%	$4.3B+1.3%	$4.2B+2.9%	$4.1B+2.7%	$4.0B+8.6%	$3.7B
Cost of Revenue	$4.7B	$4.2B+2.8%	$4.1B-0.6%	$4.2B+2.1%	$4.1B+6.6%	$3.8B+15.8%	$3.3B+3.1%	$3.2B-0.2%	$3.2B+9.3%	$2.9B+13.8%	$2.6B+0.8%	$2.6B+1.8%	$2.5B+2.3%	$2.5B+2.6%	$2.4B+10.2%	$2.2B
Gross Profit	$3.0B	$2.6B0.0%	$2.6B+3.5%	$2.5B+10.0%	$2.3B-8.8%	$2.5B+8.4%	$2.3B+7.2%	$2.1B+2.5%	$2.1B+16.7%	$1.8B-2.1%	$1.8B+5.4%	$1.7B+0.4%	$1.7B+3.9%	$1.7B+3.0%	$1.6B+6.3%	$1.5B
R&D Expenses	N/A	$106.1M+3.1%	$102.9M+8.4%	$94.9M+8.5%	$87.5M+0.2%	$87.3M+27.3%	$68.6M+1.9%	$67.3M-3.0%	$69.4M+5.0%	$66.1M+8.4%	$61.0M+0.3%	$60.8M-1.9%	$62.0M+1.1%	$61.3M+6.1%	$57.8M-0.5%	$58.1M
SG&A Expenses	$1.7B	$1.5B-1.4%	$1.5B+2.9%	$1.5B+8.9%	$1.4B-3.3%	$1.4B+9.6%	$1.3B+9.8%	$1.2B+0.3%	$1.2B+12.8%	$1.0B-12.2%	$1.2B+4.2%	$1.1B+0.5%	$1.1B+4.4%	$1.1B+3.4%	$1.0B+5.8%	$982.2M
Operating Income	$1.0B	$1.1B+1.0%	$1.1B+10.1%	$963.0M+11.5%	$863.6M-14.9%	$1.0B+1.6%	$999.5M+4.4%	$957.7M+7.5%	$891.1M+27.3%	$699.8M+9.2%	$641.0M+16.9%	$548.4M-9.1%	$603.0M+9.5%	$550.5M-4.8%	$578.3M+7.0%	$540.3M
EBITDA	N/A	$1.3B+2.6%	$1.3B+9.2%	$1.2B+9.2%	$1.1B-11.4%	$1.2B+3.2%	$1.2B+4.3%	$1.1B+7.2%	$1.0B+26.3%	$825.0M+10.0%	$749.7M+14.6%	$654.3M-7.3%	$705.7M+7.5%	$656.5M-3.6%	$681.1M+6.7%	$638.6M
Interest Expense	$224.9M	$196.2M-6.3%	$209.4M+0.6%	$208.2M+39.6%	$149.1M+9.2%	$136.6M+0.7%	$135.6M-17.9%	$165.2M-5.4%	$174.6M+82.4%	$95.7M+70.9%	$56.0M+5.1%	$53.3M+7.2%	$49.7M-6.8%	$53.3M-2.4%	$54.6M+6.6%	$51.2M
Income Tax	$227.7M	$195.8M+6.4%	$184.0M+5.4%	$174.5M+3.5%	$168.6M-12.5%	$192.7M+10.2%	$174.9M+11.1%	$157.4Mn/m	-$157.3M-204.0%	$151.3M-1.1%	$153.0M+16.5%	$131.3M-10.0%	$145.9M+9.2%	$133.6M-4.4%	$139.8M-2.0%	$142.6M
Net Income	$1.5B	$789.4M+0.1%	$788.5M+15.9%	$680.6M-0.2%	$682.0M-9.7%	$755.3M+1.1%	$747.4M+6.4%	$702.7M-24.7%	$933.4M+95.5%	$477.4M+1.1%	$472.3M+17.6%	$401.6M-8.3%	$437.9M+12.6%	$389.0M-4.6%	$407.8M+9.0%	$374.2M
EPS (Basic)	N/A	$2.940.0%	$2.94+15.7%	$2.540.0%	$2.54-10.2%	$2.83+1.1%	$2.80+5.7%	$2.65-25.4%	$3.55	$3.77+1.1%	$3.73+18.8%	$3.14-6.8%	$3.37+14.6%	$2.94-4.2%	$3.07+8.9%	$2.82
EPS (Diluted)	$5.53	$2.93+0.3%	$2.92+15.9%	$2.520.0%	$2.52-10.0%	$2.80+0.7%	$2.78+6.1%	$2.62-25.1%	$3.50	$3.72+0.8%	$3.69+18.6%	$3.11-6.9%	$3.34+14.8%	$2.91-4.3%	$3.04+9.0%	$2.79
Diluted Shares (Avg)	N/A	269M-0.1%	270M-0.1%	270M-0.1%	270M+0.1%	270M+0.3%	269M+0.4%	268M+0.6%	267M	128M+0.3%	128M-0.9%	129M-1.4%	131M-1.9%	134M-0.5%	134M0.0%	134M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$2.0B+17.4%	$1.9B+16.7%	$1.9B+16.7%	$1.9B+2.9%	$1.7B+2.7%	$1.7B+1.0%	$1.6B+0.2%	$1.8B+2.6%
Cost of Revenue	$1.2B+13.9%	$1.2B+11.7%	$1.2B+16.3%	$1.1B+5.0%	$1.1B+4.8%	$1.0B+1.3%	$1.0B-0.2%	$1.1B+2.3%
Gross Profit	$794.9M+23.2%	$778.2M+25.0%	$708.9M+17.4%	$720.3M-0.3%	$645.1M-0.7%	$622.8M+0.5%	$604.0M+0.8%	$722.2M+3.0%
SG&A Expenses	$436.4M+23.8%	$441.8M+21.3%	$456.3M+20.5%	$404.8M-2.3%	$352.5M-2.5%	$364.2M-5.1%	$378.8M+4.8%	$414.4M+6.3%
Operating Income	$217.0M-24.8%	$276.4M+12.4%	$227.5M+1.0%	$311.1M+1.6%	$288.7M+0.8%	$245.8M+5.0%	$225.2M-3.6%	$306.2M+3.0%
EBITDA	$293.6M-16.1%	$349.9M+15.5%	$290.5M+4.1%	$370.3M+3.6%	$349.9M+2.6%	$302.9M+4.0%	$279.0M-0.1%	$357.5M+3.3%
Interest Expense	$68.4M+36.3%	$62.7M+22.9%	$47.3M-2.5%	$46.5M-11.8%	$50.2M-6.2%	$51.0M-3.6%	$48.5M-3.6%	$52.7M0.0%
Income Tax	$49.9M+27.0%	$63.5M+28.8%	$48.7M+17.1%	$65.6M-2.4%	$39.3M-4.1%	$49.3M+88.2%	$41.6M-16.1%	$67.2M+17.7%
Net Income	$97.6M-56.7%	$150.1M-14.2%	$1.0B+526.1%	$226.6M+5.3%	$225.5M+1.1%	$175.0M-5.0%	$162.3M-2.2%	$215.2M-1.9%
EPS (Basic)	$0.36-57.1%	$0.56-13.8%	$3.78+530.0%	$0.84+3.7%	$0.84+1.2%	$0.65-5.8%	$0.60-3.2%	$0.81-1.2%
EPS (Diluted)	$0.36-57.1%	$0.56-13.8%	$3.77+528.3%	$0.84+6.3%	$0.84+1.2%	$0.65-4.4%	$0.60-3.2%	$0.79-2.5%
Diluted Shares (Avg)	269M0.0%	269M-0.1%	269M0.0%	N/A	269M-0.1%	269M-0.1%	270M0.0%	N/A

Not reported in any period shown, so not listed: R&D Expenses.

MKC Balance Sheet

MKC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$13.2B+1.0%	$13.1B+1.6%	$12.9B-2.0%	$13.1B+1.7%	$12.9B+6.8%	$12.1B+16.7%	$10.4B+1.0%	$10.3B-1.2%	$10.4B+124.0%	$4.6B+3.7%	$4.5B+2.1%	$4.4B-1.5%	$4.4B+6.8%	$4.2B+1.9%	$4.1B
Current Assets	$2.1B0.0%	$2.1B+6.9%	$2.0B-16.1%	$2.4B+8.7%	$2.2B+5.4%	$2.1B+34.4%	$1.6B+4.8%	$1.5B-8.5%	$1.6B+13.7%	$1.4B+4.7%	$1.4B-4.2%	$1.4B+3.4%	$1.4B+6.6%	$1.3B+5.1%	$1.2B
Cash & Equivalents	$95.9M-48.5%	$186.1M+11.7%	$166.6M-50.1%	$334.0M-5.0%	$351.7M-17.0%	$423.6M+172.6%	$155.4M+60.9%	$96.6M-48.3%	$186.8M+57.8%	$118.4M+5.2%	$112.6M+45.7%	$77.3M+22.7%	$63.0M-20.3%	$79.0M+46.6%	$53.9M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$1.3B+2.6%	$1.2B+10.1%	$1.1B-15.9%	$1.3B+13.3%	$1.2B+14.5%	$1.0B+28.9%	$801.2M+1.9%	$786.3M-0.9%	$793.3M+4.9%	$756.3M+136.4%	$319.9M+5.5%	$303.2M-0.5%	$304.6M+11.5%	$273.2M+1.6%	$268.8M
Accounts Receivable	$628.9M+7.1%	$587.4M0.0%	$587.5M+2.4%	$573.7M+4.4%	$549.5M+4.0%	$528.5M+5.1%	$502.9M-2.9%	$518.1M-6.7%	$555.1M+19.3%	$465.2M+2.2%	$455.2M-7.8%	$493.6M-0.4%	$495.5M+6.4%	$465.9M+9.1%	$427.0M
Long-Term Investments	$132.9M+1.8%	$130.5M+13.5%	$115.0M-0.1%	$115.1M-16.2%	$137.3M+5.7%	$129.9M+4.4%	$124.4M+3.0%	$120.8M-4.9%	$127.0M+9.3%	$116.2M+3.2%	$112.6M-0.4%	$113.0M+9.3%	$103.4M+20.1%	$86.1M+20.6%	$71.4M
Goodwill	$5.3B+1.4%	$5.2B-0.6%	$5.3B+0.9%	$5.2B-2.3%	$5.3B+7.0%	$5.0B+10.7%	$4.5B-0.5%	$4.5B+0.8%	$4.5B+153.5%	$1.8B+0.7%	$1.8B+2.2%	$1.7B-4.2%	$1.8B+6.1%	$1.7B+0.1%	$1.7B
Total Liabilities	$7.4B-4.1%	$7.8B-0.3%	$7.8B-7.7%	$8.4B-0.6%	$8.5B+4.1%	$8.1B+18.0%	$6.9B-2.4%	$7.1B-9.5%	$7.8B+160.7%	$3.0B+7.6%	$2.8B+6.9%	$2.6B+4.1%	$2.5B+1.5%	$2.5B-0.2%	$2.5B
Current Liabilities	$3.1B+6.2%	$2.9B-7.0%	$3.1B-9.7%	$3.4B+6.5%	$3.2B+5.8%	$3.0B+41.4%	$2.2B+7.6%	$2.0B+2.8%	$1.9B+36.9%	$1.4B+14.9%	$1.2B+10.4%	$1.1B+5.5%	$1.1B-10.5%	$1.2B+19.6%	$993.3M
Non-Current Liabilities	$4.4B-10.3%	$4.9B+4.1%	$4.7B-6.3%	$5.0B-5.0%	$5.3B+3.0%	$5.1B+7.4%	$4.8B-6.3%	$5.1B-13.6%	$5.9B+272.5%	$1.6B+1.8%	$1.5B+4.3%	$1.5B+3.1%	$1.4B+12.6%	$1.3B-13.4%	$1.5B
Long-Term Debt	$3.1B-13.6%	$3.6B+7.6%	$3.3B-8.3%	$3.6B-8.3%	$4.0B+5.8%	$3.8B+3.5%	$3.6B-10.5%	$4.1B-8.8%	$4.4B+321.6%	$1.1B+0.2%	$1.1B+3.7%	$1.0B-0.5%	$1.0B+30.8%	$779.2M-24.3%	$1.0B
Total Equity	$5.7B+8.4%	$5.3B+4.6%	$5.1B+8.1%	$4.7B+6.1%	$4.4B+12.4%	$3.9B+14.0%	$3.4B+8.6%	$3.2B+23.9%	$2.6B+57.4%	$1.6B-2.6%	$1.7B-6.8%	$1.8B-7.3%	$1.9B+14.8%	$1.7B+5.1%	$1.6B
Retained Earnings	$3.8B+7.7%	$3.5B+9.1%	$3.2B+7.5%	$3.0B+8.6%	$2.8B+15.2%	$2.4B+17.5%	$2.1B+16.8%	$1.8B+50.9%	$1.2B+10.4%	$1.1B+1.9%	$1.0B+5.5%	$982.6M+1.3%	$970.4M+3.8%	$934.6M+11.4%	$838.8M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$16.7B+25.7%	$16.5B+24.9%	$16.3B+26.7%	$13.2B+1.0%	$13.2B+0.3%	$13.2B+1.6%	$12.9B+0.1%	$13.1B+1.6%
Current Assets	$2.9B+30.6%	$2.8B+28.7%	$2.6B+29.6%	$2.1B0.0%	$2.2B-0.9%	$2.2B+4.7%	$2.0B-0.4%	$2.1B+6.9%
Cash & Equivalents	$331.1M+248.9%	$331.2M+166.9%	$177.7M+72.9%	$95.9M-48.5%	$94.9M-52.7%	$124.1M-25.4%	$102.8M-42.2%	$186.1M+11.7%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Inventory	$721.1M+9.7%	$694.7M+13.3%	$665.4M+9.5%	$1.3B+2.6%	$657.2M+1.9%	$613.0M-0.9%	$607.9M+5.9%	$1.2B+10.1%
Accounts Receivable	$831.5M+24.3%	$709.4M+21.4%	$829.2M+60.4%	$628.9M+7.1%	$668.7M+1.2%	$584.5M-2.3%	$516.9M-8.9%	$587.4M0.0%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$132.9M+1.8%	$0n/m	$0n/m	$0n/m	$130.5M+13.5%
Goodwill	$6.3B+18.6%	$6.3B+18.9%	$6.3B+21.3%	$5.3B+1.4%	$5.3B+0.7%	$5.3B+0.7%	$5.2B-0.9%	$5.2B-0.6%
Total Liabilities	$9.1B+21.4%	$8.9B+17.8%	$8.8B+18.0%	$7.4B-4.1%	$7.5B-3.7%	$7.6B-1.0%	$7.5B-2.4%	$7.8B-0.3%
Current Liabilities	$4.4B+41.7%	$3.6B+12.1%	$3.4B+11.0%	$3.1B+6.2%	$3.1B-0.8%	$3.2B+6.7%	$3.1B+4.3%	$2.9B-7.0%
Non-Current Liabilities	$4.6B+6.9%	$5.3B+21.9%	$5.3B+23.0%	$4.4B-10.3%	$4.3B-5.8%	$4.4B-5.9%	$4.3B-6.7%	$4.9B+4.1%
Long-Term Debt	$2.9B-6.4%	$3.6B+16.1%	$3.6B+16.4%	$3.1B-13.6%	$3.1B-7.1%	$3.1B-6.8%	$3.1B-7.0%	$3.6B+7.6%
Total Equity	$7.0B+21.7%	$7.0B+24.9%	$7.0B+28.7%	$5.7B+8.4%	$5.8B+6.1%	$5.6B+5.1%	$5.4B+3.6%	$5.3B+4.6%
Retained Earnings	$4.8B+25.2%	$4.8B+29.5%	$4.8B+30.6%	$3.8B+7.7%	$3.8B+7.4%	$3.7B+7.4%	$3.7B+8.2%	$3.5B+9.1%

MKC Cash Flow Statement

MKC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.1B	$962.2M+4.4%	$921.9M-25.5%	$1.2B+89.9%	$651.5M-21.3%	$828.3M-20.5%	$1.0B+10.0%	$946.8M+15.3%	$821.2M+0.7%	$815.3M+23.9%	$658.1M+11.5%	$590.0M+17.2%	$503.6M+8.3%	$465.2M+2.2%	$455.0M+33.8%	$340.0M
Depreciation & Amortization	N/A	$231.3M+10.8%	$208.8M+4.8%	$199.3M-0.6%	$200.6M+7.7%	$186.3M+12.9%	$165.0M+3.9%	$158.8M+5.4%	$150.7M+20.4%	$125.2M+15.2%	$108.7M+2.6%	$105.9M+3.1%	$102.7M-3.1%	$106.0M+3.1%	$102.8M+4.6%	$98.3M
Stock-Based Compensation	N/A	$46.2M-2.5%	$47.4M-25.2%	$63.4M+5.1%	$60.3M-9.5%	$66.6M+44.8%	$46.0M+23.7%	$37.2M+45.3%	$25.6M+7.1%	$23.9M-6.6%	$25.6M+36.9%	$18.7M+2.7%	$18.2M-2.7%	$18.7M-7.4%	$20.2M+55.4%	$13.0M
Capital Expenditures	$214.9M	$221.8M-19.3%	$274.9M+4.2%	$263.9M+0.7%	$262.0M-5.8%	$278.0M+23.4%	$225.3M+29.7%	$173.7M+2.7%	$169.1M-7.3%	$182.4M+18.6%	$153.8M+19.8%	$128.4M-3.2%	$132.7M+32.8%	$99.9M-9.4%	$110.3M+14.1%	$96.7M
Free Cash Flow	$925.9M	$740.4M+14.4%	$647.0M-33.5%	$973.4M+149.9%	$389.5M-29.2%	$550.3M-32.6%	$816.0M+5.5%	$773.1M+18.6%	$652.1M+3.0%	$632.9M+25.5%	$504.3M+9.3%	$461.6M+24.5%	$370.9M+1.5%	$365.3M+6.0%	$344.7M+41.7%	$243.3M
Investing Cash Flow	-$944.1M	-$255.2Mn/m	-$269.0Mn/m	-$260.5Mn/m	-$146.4Mn/m	-$908.6Mn/m	-$1.0Bn/m	-$171.0Mn/m	-$158.5Mn/m	-$4.5Bn/m	-$267.1Mn/m	-$338.9Mn/m	-$131.6Mn/m	-$239.7Mn/m	-$109.0Mn/m	-$537.5M
Financing Cash Flow	$27.7M	-$840.9Mn/m	-$583.1Mn/m	-$1.2Bn/m	-$487.2M-2314.5%	$22.0M-90.0%	$220.9Mn/m	-$725.8Mn/m	-$751.1M-120.0%	$3.8Bn/m	-$371.5Mn/m	-$199.6Mn/m	-$348.9Mn/m	-$245.9Mn/m	-$324.3M-272.7%	$187.8M
Dividends Paid	$516.2M	$483.0M+7.1%	$451.0M+7.8%	$418.5M+5.5%	$396.7M+9.2%	$363.3M+10.1%	$330.1M+9.2%	$302.2M+10.5%	$273.4M+15.1%	$237.6M+9.1%	$217.8M+6.3%	$204.9M+6.5%	$192.4M+6.9%	$179.9M+9.2%	$164.7M+10.9%	$148.5M
Share Buybacks	$16.5M	$34.8M-34.5%	$53.1M+48.7%	$35.7M-8.0%	$38.8M+351.2%	$8.6M-81.8%	$47.3M-50.3%	$95.1M+52.6%	$62.3M-54.8%	$137.8M-43.2%	$242.7M+66.5%	$145.8M-40.3%	$244.3M+37.7%	$177.4M+34.2%	$132.2M+48.0%	$89.3M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$168.1M-35.0%	$379.8M+727.5%	$50.9M-55.9%	$542.0M+18.2%	$258.8M+60.0%	$45.9M-71.9%	$115.5M-16.5%	$458.7M-20.5%
Depreciation & Amortization	$76.6M+25.2%	$73.5M+28.7%	$63.0M+17.1%	$59.2M+15.4%	$61.2M+12.1%	$57.1M0.0%	$53.8M+17.5%	$51.3M+4.9%
Stock-Based Compensation	$5.2M-32.5%	$8.6M-10.4%	$20.7M+3.5%	N/A	$7.7M-12.5%	$9.6M-50.5%	$20.0M+70.9%	N/A
Capital Expenditures	$56.0M+6.3%	$42.7M-11.6%	$32.5M-12.4%	$83.7M-2.2%	$52.7M-10.7%	$48.3M-29.3%	$37.1M-40.2%	$85.6M+11.6%
Free Cash Flow	$112.1M-45.6%	$337.1Mn/m	$18.4M-76.5%	$458.3M+22.8%	$206.1M+100.7%	-$2.4M-102.5%	$78.4M+2.6%	$373.1M-25.5%
Investing Cash Flow	-$56.0Mn/m	-$42.7Mn/m	-$762.4Mn/m	-$83.0Mn/m	-$67.0Mn/m	-$68.1Mn/m	-$37.1Mn/m	-$79.9Mn/m
Financing Cash Flow	-$112.4Mn/m	-$179.0M-1555.3%	$781.7Mn/m	-$462.6Mn/m	-$235.4Mn/m	$12.3Mn/m	-$155.2Mn/m	-$377.2Mn/m
Dividends Paid	$129.1M+7.0%	$137.4M+13.7%	$128.9M+6.8%	$120.8M+7.2%	$120.7M+6.9%	$120.8M+7.2%	$120.7M+7.1%	$112.7M+7.6%
Share Buybacks	$0-100.0%	$0-100.0%	$10.9M-36.6%	$5.6M-76.8%	$2.7M-89.0%	$9.3M+121.4%	$17.2M+5633.3%	$24.1M+167.8%

MKC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MKC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	37.9%-0.6pp	38.5%+1.0pp	37.6%+1.7pp	35.8%-3.7pp	39.5%-1.6pp	41.1%+1.0pp	40.1%+0.6pp	39.5%+1.5pp	37.9%-3.6pp	41.5%+1.1pp	40.4%-0.3pp	40.8%+0.4pp	40.4%+0.1pp	40.3%-0.9pp	41.2%
Operating Margin	15.7%-0.1pp	15.8%+1.3pp	14.4%+0.8pp	13.6%-2.5pp	16.1%-1.8pp	17.8%-0.1pp	17.9%+1.1pp	16.8%+2.0pp	14.8%+0.3pp	14.5%+1.8pp	12.8%-1.5pp	14.2%+0.9pp	13.4%-1.1pp	14.4%-0.2pp	14.6%
Net Margin	11.5%-0.2pp	11.7%+1.5pp	10.2%-0.5pp	10.7%-1.2pp	11.9%-1.4pp	13.3%+0.2pp	13.1%-4.5pp	17.6%+7.5pp	10.1%-0.6pp	10.7%+1.4pp	9.3%-1.0pp	10.3%+0.9pp	9.4%-0.7pp	10.2%0.0pp	10.1%
Return on Equity	13.8%-1.1pp	14.9%+1.4pp	13.5%-1.1pp	14.6%-2.5pp	17.1%-1.9pp	19.0%-1.4pp	20.4%-9.0pp	29.4%+10.8pp	18.6%-10.4pp	29.0%+5.0pp	24.1%-0.4pp	24.4%+4.3pp	20.1%-4.1pp	24.2%+0.9pp	23.4%
Return on Assets	6.0%-0.1pp	6.0%+0.7pp	5.3%+0.1pp	5.2%-0.7pp	5.9%-0.3pp	6.2%-0.6pp	6.8%-2.3pp	9.1%+4.5pp	4.6%-5.6pp	10.2%+1.2pp	9.0%-1.0pp	10.0%+1.2pp	8.7%-1.0pp	9.8%+0.6pp	9.2%
Current Ratio	0.700.0x	0.74+0.1x	0.650.0x	0.700.0x	0.680.0x	0.680.0x	0.720.0x	0.74-0.1x	0.83-0.2x	1.00-0.1x	1.10-0.2x	1.260.0x	1.29+0.2x	1.08-0.1x	1.23
Debt-to-Equity	0.54-0.1x	0.680.0x	0.66-0.1x	0.78-0.1x	0.90-0.1x	0.96-0.1x	1.05-0.2x	1.28-0.5x	1.74+1.1x	0.650.0x	0.63+0.1x	0.570.0x	0.53+0.1x	0.46-0.2x	0.64
Liabilities-to-Equity	1.30-0.2x	1.47-0.1x	1.54-0.3x	1.80-0.1x	1.92-0.2x	2.08+0.1x	2.00-0.2x	2.23-0.8x	3.05+1.2x	1.84+0.2x	1.67+0.2x	1.45+0.2x	1.29-0.2x	1.46-0.1x	1.54
Asset Turnover	0.520.0x	0.510.0x	0.520.0x	0.480.0x	0.490.0x	0.46-0.1x	0.520.0x	0.52+0.1x	0.46-0.5x	0.950.0x	0.960.0x	0.970.0x	0.930.0x	0.96+0.1x	0.90
FCF Margin	10.8%+1.2pp	9.6%-5.0pp	14.6%+8.5pp	6.1%-2.6pp	8.7%-5.9pp	14.6%+0.1pp	14.5%+2.2pp	12.3%-1.1pp	13.4%+2.0pp	11.4%+0.7pp	10.7%+2.0pp	8.7%-0.1pp	8.9%+0.3pp	8.6%+2.0pp	6.6%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	39.3%+1.9pp	40.2%+2.6pp	37.8%+0.2pp	38.9%-1.2pp	37.4%-1.3pp	37.5%-0.2pp	37.6%+0.2pp	40.2%+0.2pp
Operating Margin	10.7%-6.0pp	14.3%-0.5pp	12.1%-1.9pp	16.8%-0.2pp	16.7%-0.3pp	14.8%+0.6pp	14.0%-0.5pp	17.0%+0.1pp
Net Margin	4.8%-8.3pp	7.8%-2.8pp	54.2%+44.1pp	12.3%+0.3pp	13.1%-0.2pp	10.5%-0.7pp	10.1%-0.3pp	12.0%-0.5pp
Return on Equity	1.4%-2.5pp	2.1%-1.0pp	14.6%+11.6pp	4.0%-0.1pp	3.9%-0.2pp	3.1%-0.3pp	3.0%-0.2pp	4.1%-0.3pp
Return on Assets	0.6%-1.1pp	0.9%-0.4pp	6.2%+5.0pp	1.7%+0.1pp	1.7%0.0pp	1.3%-0.1pp	1.3%0.0pp	1.7%-0.1pp
Current Ratio	0.66-0.1x	0.78+0.1x	0.76+0.1x	0.700.0x	0.710.0x	0.680.0x	0.650.0x	0.74+0.1x
Debt-to-Equity	0.41-0.1x	0.510.0x	0.52-0.1x	0.54-0.1x	0.54-0.1x	0.55-0.1x	0.57-0.1x	0.680.0x
Liabilities-to-Equity	1.290.0x	1.27-0.1x	1.26-0.1x	1.30-0.2x	1.30-0.1x	1.35-0.1x	1.37-0.1x	1.47-0.1x
Asset Turnover	0.120.0x	0.120.0x	0.110.0x	0.140.0x	0.130.0x	0.130.0x	0.120.0x	0.140.0x
FCF Margin	5.5%-6.4pp	17.4%+17.6pp	1.0%-3.9pp	24.8%+4.0pp	11.9%+5.8pp	-0.1%-5.9pp	4.9%+0.1pp	20.8%-7.8pp

Note: The current ratio is below 1.0 (0.70), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
McCormick & Company, Incorporated Non-VTG CS MKC	FY2025	$6.8B	$789.4M	11.5%	$12.4B	50/100
Hormel Foods Corporation HRL	FY2025	$12.1B	$478.2M	4.0%	$11.5B	51/100
General Mills, Inc. GIS	FY2026	$18.4B	-$87.6M	-0.5%	$17.9B	36/100
The J.M. Smucker Company SJM	FY2026	$9.1B	-$138.7M	-1.5%	$13.6B	34/100
The Kraft Heinz Company KHC	FY2025	$24.9B	-$5.8B	-23.4%	$28.5B	38/100

Where McCormick & Company, Incorporated Non-VTG CS Ranks

Frequently Asked Questions

What is McCormick & Company, Incorporated Non-VTG CS's annual revenue?

McCormick & Company, Incorporated Non-VTG CS (MKC) reported $6.8B in total revenue for fiscal year 2025. This represents a 1.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is McCormick & Company, Incorporated Non-VTG CS's revenue growing?

McCormick & Company, Incorporated Non-VTG CS (MKC) revenue grew by 1.7% year-over-year, from $6.7B to $6.8B in fiscal year 2025.

Is McCormick & Company, Incorporated Non-VTG CS profitable?

Yes, McCormick & Company, Incorporated Non-VTG CS (MKC) reported a net income of $1.5B over the trailing 12 months to August 31, 2026. In fiscal year 2025 it reported a net income of $789.4M, with a net profit margin of 11.5%.

What is McCormick & Company, Incorporated Non-VTG CS's EBITDA?

McCormick & Company, Incorporated Non-VTG CS (MKC) had EBITDA of $1.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does McCormick & Company, Incorporated Non-VTG CS have?

As of fiscal year 2025, McCormick & Company, Incorporated Non-VTG CS (MKC) had $95.9M in cash and equivalents against $3.1B in long-term debt.

What is McCormick & Company, Incorporated Non-VTG CS's gross margin?

McCormick & Company, Incorporated Non-VTG CS (MKC) had a gross margin of 37.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is McCormick & Company, Incorporated Non-VTG CS's operating margin?

McCormick & Company, Incorporated Non-VTG CS (MKC) had an operating margin of 15.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is McCormick & Company, Incorporated Non-VTG CS's net profit margin?

McCormick & Company, Incorporated Non-VTG CS (MKC) had a net profit margin of 11.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does McCormick & Company, Incorporated Non-VTG CS pay dividends?

Yes, McCormick & Company, Incorporated Non-VTG CS (MKC) paid $1.83 per share in dividends during fiscal year 2025.

What is McCormick & Company, Incorporated Non-VTG CS's return on equity (ROE)?

McCormick & Company, Incorporated Non-VTG CS (MKC) has a return on equity of 13.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is McCormick & Company, Incorporated Non-VTG CS's free cash flow?

McCormick & Company, Incorporated Non-VTG CS (MKC) generated $740.4M in free cash flow during fiscal year 2025. This represents a 14.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is McCormick & Company, Incorporated Non-VTG CS's operating cash flow?

McCormick & Company, Incorporated Non-VTG CS (MKC) generated $962.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are McCormick & Company, Incorporated Non-VTG CS's total assets?

McCormick & Company, Incorporated Non-VTG CS (MKC) had $13.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are McCormick & Company, Incorporated Non-VTG CS's capital expenditures?

McCormick & Company, Incorporated Non-VTG CS (MKC) invested $221.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does McCormick & Company, Incorporated Non-VTG CS spend on research and development?

McCormick & Company, Incorporated Non-VTG CS (MKC) invested $106.1M in research and development during fiscal year 2025.

Does McCormick & Company, Incorporated Non-VTG CS buy back shares?

Yes, McCormick & Company, Incorporated Non-VTG CS (MKC) spent $34.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is McCormick & Company, Incorporated Non-VTG CS's current ratio?

McCormick & Company, Incorporated Non-VTG CS (MKC) had a current ratio of 0.70 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is McCormick & Company, Incorporated Non-VTG CS's debt-to-equity ratio?

McCormick & Company, Incorporated Non-VTG CS (MKC) had a debt-to-equity ratio of 0.54 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is McCormick & Company, Incorporated Non-VTG CS's liabilities-to-equity ratio?

McCormick & Company, Incorporated Non-VTG CS (MKC) had a liabilities-to-equity ratio of 1.30 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is McCormick & Company, Incorporated Non-VTG CS's return on assets (ROA)?

McCormick & Company, Incorporated Non-VTG CS (MKC) had a return on assets of 6.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is McCormick & Company, Incorporated Non-VTG CS's P/E ratio?

McCormick & Company, Incorporated Non-VTG CS (MKC) trades at 8.3x earnings, its market capitalization divided by $1.5B net income, trailing 12 months to August 31, 2026. The market capitalization is $12.4B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is McCormick & Company, Incorporated Non-VTG CS's price-to-sales ratio?

McCormick & Company, Incorporated Non-VTG CS (MKC) trades at 1.6x sales, its market capitalization divided by $7.7B revenue, trailing 12 months to August 31, 2026. The market capitalization is $12.4B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is McCormick & Company, Incorporated Non-VTG CS's Altman Z-Score?

McCormick & Company, Incorporated Non-VTG CS (MKC) has an Altman Z-Score of 2.11, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is McCormick & Company, Incorporated Non-VTG CS's Piotroski F-Score?

McCormick & Company, Incorporated Non-VTG CS (MKC) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are McCormick & Company, Incorporated Non-VTG CS's earnings high quality?

McCormick & Company, Incorporated Non-VTG CS (MKC) has an earnings quality ratio of 1.22x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can McCormick & Company, Incorporated Non-VTG CS cover its interest payments?

McCormick & Company, Incorporated Non-VTG CS (MKC) has an interest coverage ratio of 5.46x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is McCormick & Company, Incorporated Non-VTG CS?

McCormick & Company, Incorporated Non-VTG CS (MKC) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.